CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 13 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,743 | -31.9% | 26,529 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $34,886 | -17.3% | 26,529 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $42,181 | -74.5% | 26,529 | -48.6% | 0.00% | -75.0% |
| Q4 2022 | $165,146 | +77.6% | 51,608 | +38.1% | 0.00% | +100.0% |
| Q3 2022 | $93,000 | -39.2% | 37,371 | -9.5% | 0.00% | -50.0% |
| Q2 2022 | $153,000 | -22.7% | 41,300 | +0.0% | 0.00% | -20.0% |
| Q1 2022 | $198,000 | 0.0% | 41,298 | +44.1% | 0.01% | 0.0% |
| Q4 2021 | $198,000 | -58.9% | 28,653 | -34.1% | 0.01% | -61.5% |
| Q3 2021 | $482,000 | -53.7% | 43,459 | -20.6% | 0.01% | -60.6% |
| Q2 2021 | $1,041,000 | -41.3% | 54,729 | -11.4% | 0.03% | -50.0% |
| Q1 2021 | $1,773,000 | – | 61,761 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,578,174 | $74,019,000 | 0.69% |
| CVI Holdings, LLC | 93,750 | $2,692,000 | 0.19% |
| Maven Securities LTD | 126,562 | $3,634,000 | 0.16% |
| BOOTHBAY FUND MANAGEMENT, LLC | 61,761 | $1,773,000 | 0.07% |
| MEITAV INVESTMENT HOUSE LTD | 8,311 | $239,000 | 0.01% |
| Ironwood Financial, llc | 167 | $5,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 76 | $2,000 | 0.00% |
| Renaissance Technologies | 7,023 | $202,000 | 0.00% |
| UBS Group AG | 834 | $24,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |